arsenic has been researched along with Ameloblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beachy, PA; Biscocho, J; Gong, X; Jones, CD; Koyota, S; Kwei, KA; McClary, AC; Myers, BR; Neahring, L; Ng, T; Odegaard, JI; Pelham, RJ; Pollack, JR; Qu, K; Rubin, BP; Sugiyama, T; Sweeney, RT; Troxell, ML; Varma, S; West, RB; Zehnder, JL | 1 |
1 other study(ies) available for arsenic and Ameloblastoma
Article | Year |
---|---|
Identification of recurrent SMO and BRAF mutations in ameloblastomas.
Topics: Ameloblastoma; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Proliferation; High-Throughput Nucleotide Sequencing; Humans; Indoles; Jaw Neoplasms; Mutation; Oxides; Polymerase Chain Reaction; Proto-Oncogene Proteins B-raf; Receptors, G-Protein-Coupled; Smoothened Receptor; Sulfonamides; Tumor Cells, Cultured; Vemurafenib | 2014 |